Samuel Wright
20Patents
8h-index
17Co-inventors
72Inventor score
Filing activity: Mar 31, 1989 → Jul 6, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5147637A | Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma | Human Necessities | 36 | Expired |
| US5322699A | Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1) | Human Necessities | 23 | Expired |
| USD663119S1 | Combined backpack and luggage | General | 14 | Active |
| US8999920B2 | Reconstituted high density lipoprotein formulation and production method thereof | Human Necessities | 12 | Active |
| US5730980A | Methods and compositions for ameliorating the symptoms of sepsis | Human Necessities | 12 | Expired |
| US6680340B2 | Anti-hypercholesterolemic drug combination | Human Necessities | 9 | Expired |
| US5928624A | Compositions for neutralization of lipopolysaccharides | Emerging Cross-Sectional Technologies | 9 | Expired |
| US9439946B2 | Reconstituted high density lipoprotein formulation and production method thereof | Human Necessities | 8 | Active |
| US5869055A | Anti-inflammatory CD14 polypeptides | Human Necessities | 8 | Expired |
| US6045795A | Methods and compositions for ameliorating the symptoms of sepsis | Human Necessities | 7 | Expired |
| US5652352A | Afamin: a human serum albumin-like gene | Chemistry; Metallurgy | 6 | Expired |
| US5766593A | Anti-inflammatory CD14 peptides | Human Necessities | 4 | Expired |
| US10335457B2 | Reconstituted high density lipoprotein formulation and production method thereof | Human Necessities | 4 | Active |
| US5767243A | Afamin: a human serum albumin-like protein | Chemistry; Metallurgy | 4 | Expired |
| US6297049A | Methods and compositions for ameliorating the symptoms of sepsis | Human Necessities | 2 | Expired |
| US11058747B2 | Reconstituted high density lipoprotein formulation and production method thereof | Human Necessities | 2 | Active |
| US5932536A | Compositions for neutralization of lipopolysaccharides | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6495332B2 | Methods and compositions for ameliorating the symptoms of sepsis | Human Necessities | 1 | Expired |
| US5436321A | Antibodies to the lipopolysaccharide bonding opsonin septin | Human Necessities | 1 | Expired |
| US11723953B2 | Reconstituted high density lipoprotein formulation and production method thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.